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Introduction
Thyroid papillary carcinoma represents 75% of all thyroid
cancer cases. It is more prevalent in the young and middle
age group of patients. Distant metastases occur in 10% of
cases. Metastases to lymph nodes can be the first sign of
microcarcinoma. This is a case report where thrombophle-
bitis of popliteal vein and pulmonary embolic disease
appeared to be the first manifestation of the carcinoma.
The chest CT scan showed mediastinal lymfoadenopathy
representing metastases of papillary thyroid cancer. The
18 F-FDG PET/CT scans had a major diagnostic and
prognostic value in the overall management.
Case
A 36 year old man was diagnosed with thrombophlebitis
of the right popliteal vein and pulmonary artery disease
in September 2011. Chest CT scans showed mediastinal
limphoadenopathy. The neck ultrasound imaging was
unremarkable. On 29th September 2012 EBUS/TNM
confirmed Ca papillare. The 18F-FDG PET/CT scans
showed an increasing FDG uptake in the lymph nodes
and in the left lobe of thyroid gland. FNAB of 7 mm dia-
meter thyroid nodule detected Ca papillare. In December
2012 a total strumectomy with Transcervical Extended
Mediastinal Lymphadenectomy (TEMLA) was per-
formed. The management was complicated by cardiac
tamponade. The treatment included 7x metastasectomy
as well as 3x 131 I therapy. In the 131 I scintigraphy scan
there was no uptake of 131 I. The serum level of Tg was
normal. The CT scans suggested recurrence of the carci-
noma. In January 2013 18F-FDG PET/CT scans (before
the third treatment of 131 I) showed an increasing FDG
uptake in several lymph nodes, in the left lung and the
subcutaneous lesion of chest.
Conclusions
The 18F-FDG PET/CT was proved a sensitive and specific
imaging modality, useful in assessing the progression of a
thyroid papillary carcinoma with suspected recurrences
suggested by radiological imaging.
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